Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Team-based Financial Incentives for Smoking Cessation (StPaulKorea)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Sang Haak Lee, St.Paul's Hospital, Korea
ClinicalTrials.gov Identifier:
NCT01323725
First received: March 25, 2011
Last updated: May 2, 2016
Last verified: May 2016
  Purpose
The purpose of this study is to identify the effectiveness of team-base financial incentives for increasing long-term smoking cessation among employees at St. Paul's Hospital, Korea.

Condition Intervention
Tobacco Use Disorder
Behavioral: Team-based financial incentives

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: The Effectiveness of Team-based Financial Incentives for Increasing Long-term Smoking Cessation

Resource links provided by NLM:


Further study details as provided by St.Paul's Hospital, Korea:

Primary Outcome Measures:
  • Smoking Cessation Rate [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    Self-reported and biochemically validated smoking cessation rate at 6 months post-quit date


Secondary Outcome Measures:
  • Smoking Cessation Rate [ Time Frame: 3, 9, 12 months ] [ Designated as safety issue: No ]
    Self-reported and biochemically validated smoking cessation rate at 3, 9, 12 months post-quit date


Enrollment: 28
Study Start Date: January 2011
Study Completion Date: December 2011
Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Team-based financial incentives
Team-based financial incentives
Behavioral: Team-based financial incentives
Team-based financial incentives for smoking cessation at 6 month post-quit date.

Detailed Description:

About 70% of smokers report that they want to quit, but annually 2 to 3% of smokers succeed. Smoking-cessation programs and pharmacologic therapies have been proven effective in helping smokers quit, but only a few smokers are enrolled in those programs.

Financial incentives may contribute to reinforce smoking cessation among workers through the following pathways: (1) increasing the number of tobacco users who participate in cessation effort; (2) increasing the number of tobacco user who initiate an attempt to quit; and (3) increasing the number of tobacco users who sustain a successful quit effort. Moreover, there is a number of advantages to offering smoking cessation support in the workplace, including the accessibility of the target population, the availability of occupational health support and the potential for peer pressure and peer support. In addition, team-based approach for smoking cessation could likely make use of new or existing cessation support resources offered within the workplace.

This study is a clinical trial of team-based financial incentives for smoking cessation among a sample of 60 smokers, who are health care workers from St. Paul's Hospital in Korea. Smokers will be given a usual care (counseling, education and coverage of prescription drugs) plus a package of financial incentives for self-reported and biochemically validated smoking cessation (urine or saliva cotinine). All incentives will be provided to each team at 6 months post-quit date.

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Employees of St. Paul's Hospital at work sites in Korea
  • Current smoker who report having smoked at least 5 cigarettes per day for the prior 12 months
  • Age 18 or older

Exclusion Criteria:

  • Age 17 or younger
  • Unwilling to quit smoking
  • Smoker who does not want to be enrolled in this trial
  • Planning to leave St. Paul's hospital within the next 12 months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01323725

Locations
Korea, Republic of
St.Paul's Hospital
Seoul, Korea, Republic of
Sponsors and Collaborators
St.Paul's Hospital, Korea
Investigators
Principal Investigator: Sang Haak Lee, MD St. Paul's Hospital
  More Information

Responsible Party: Sang Haak Lee, Professor, St.Paul's Hospital, Korea
ClinicalTrials.gov Identifier: NCT01323725     History of Changes
Other Study ID Numbers: StPaulKorea 
Study First Received: March 25, 2011
Last Updated: May 2, 2016
Health Authority: Korea: Institutional Review Board
Individual Participant Data  
Plan to Share IPD: Yes

Keywords provided by St.Paul's Hospital, Korea:
Team-based financial incentives
Smoking cessation

Additional relevant MeSH terms:
Tobacco Use Disorder
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on September 29, 2016